News
-
Vote Now! EP PerMed “The Story Behind Our Personalised Medicine Research Project” Video Competition
We’re excited to launch the public voting phase for the EP PerMed video competition! Young researchers of ERA PerMed funded projects have shared the innovative research projects they are participating in shaping the future of personalised medicine.
-
First in-situ visit for EP PerMed at Swedish Personalised Medicine Centres
EP PerMed conducted the first in a series of in-situ visits on 11 and 12 November 2024 in Stockholm, Sweden.
-
Report of the first EP PerMed Round Table published
EP PerMed organised a roundtable discussion on ‘De-risking Innovation in Personalised Medicine’ on 27 May 2024 in Brussels. The event accompanied the Belgian Presidency of the EU and aimed to shape the future of healthcare in the Benelux region and beyond.
EP PerMed JTC 2024
#PMTargets
With its first joint transnational call, EP PerMed aims to fund research that fosters the identification or validation of targets for personalised medicine (PM) approaches. The deadline for submission of full proposals is now closed. It is expected that funding decisions will be communicated in October 2024.
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together more than 50 partners from over 20 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.